Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125620062 | 12562006 | 2 | F | 20160721 | 20160715 | 20160727 | PER | US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-057441 | BRISTOL MYERS SQUIBB | 0.00 | F | Y | 0.00000 | 20160727 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125620062 | 12562006 | 1 | PS | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 3 MG, UNK | Y | 21436 | 3 | MG | TABLET | ||||||
| 125620062 | 12562006 | 2 | SS | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 2 MG, UNK | Y | 21436 | 2 | MG | TABLET | ||||||
| 125620062 | 12562006 | 3 | SS | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 30 MG, QD | Y | 21436 | 30 | MG | TABLET | QD | |||||
| 125620062 | 12562006 | 4 | SS | ARIPIPRAZOLE. | ARIPIPRAZOLE | 1 | Oral | 20 MG, QD | Y | 0 | 20 | MG | QD | ||||||
| 125620062 | 12562006 | 5 | SS | REXULTI | BREXPIPRAZOLE | 1 | Oral | 0.5 MG, QD | 0 | .5 | MG | QD | |||||||
| 125620062 | 12562006 | 6 | SS | REXULTI | BREXPIPRAZOLE | 1 | Oral | 2 MG, UNK | 0 | 2 | MG | ||||||||
| 125620062 | 12562006 | 7 | C | ZOLOFT | SERTRALINE HYDROCHLORIDE | 1 | Unknown | UNK | U | 0 | |||||||||
| 125620062 | 12562006 | 8 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Unknown | UNK | U | 0 | |||||||||
| 125620062 | 12562006 | 9 | C | TOPIRAMATE. | TOPIRAMATE | 1 | Unknown | U | 0 | ||||||||||
| 125620062 | 12562006 | 10 | C | KLONOPIN | CLONAZEPAM | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125620062 | 12562006 | 1 | Depression |
| 125620062 | 12562006 | 4 | Major depression |
| 125620062 | 12562006 | 5 | Major depression |
| 125620062 | 12562006 | 7 | Product used for unknown indication |
| 125620062 | 12562006 | 8 | Product used for unknown indication |
| 125620062 | 12562006 | 9 | Product used for unknown indication |
| 125620062 | 12562006 | 10 | Anxiety |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125620062 | 12562006 | Anxiety | |
| 125620062 | 12562006 | Epigastric discomfort | |
| 125620062 | 12562006 | Off label use | |
| 125620062 | 12562006 | Somnolence | |
| 125620062 | 12562006 | Therapeutic response decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125620062 | 12562006 | 3 | 2016 | 0 | ||
| 125620062 | 12562006 | 4 | 2016 | 2016 | 0 | |
| 125620062 | 12562006 | 5 | 201606 | 0 |